Deep learning-based body composition analysis from whole-body magnetic resonance imaging to predict all-cause mortality in a large western population.

Background: Manually extracted imaging-based body composition measures from a single-slice area (A) have shown associations with clinical outcomes in patients with cardiometabolic disease and cancer. With advances in artificial intelligence, fully automated volumetric (V) segmentation approaches are now possible, but it is unknown whether these measures carry prognostic value to predict mortality in the general population. Here, we developed and tested a deep learning framework to automatically quantify volumetric body composition measures from whole-body magnetic resonance imaging (MRI) and investigated their prognostic value to predict mortality in a large Western population.
Methods: The framework was developed using data from two large Western European population-based cohort studies, the UK Biobank (UKBB) and the German National Cohort (NAKO). Body composition was defined as (i) subcutaneous adipose tissue (SAT), (ii) visceral adipose tissue (VAT), (iii) skeletal muscle (SM), SM fat fraction (SMFF), and (iv) intramuscular adipose tissue (IMAT). The prognostic value of the body composition measures was assessed in the UKBB using Cox regression analysis. Additionally, we extracted body composition areas for every level of the thoracic and lumbar spine (i) to compare the proposed volumetric whole-body approach to the currently established single-slice area approach on the height of the L3 vertebra and (ii) to investigate the correlation between volumetric and single slice area body composition measures on the level of each vertebral body.
Findings: In 36,317 UKBB participants (mean age 65.1 ± 7.8 years, age range 45-84 years; 51.7% female; 1.7% [634/36,471] all-cause deaths; median follow-up 4.8 years), Cox regression revealed an independent association between V _SM (adjusted hazard ratio [aHR]: 0.88, 95% confidence interval [CI] [0.81-0.91], p = 0.00023), V _SMFF (aHR: 1.06, 95% CI [1.02-1.10], p = 0.0043), and V _IMAT (aHR: 1.19, 95% CI [1.05-1.35], p = 0.0056) and mortality after adjustment for demographics (age, sex, BMI, race) and cardiometabolic risk factors (alcohol consumption, smoking status, hypertension, diabetes, history of cancer, blood serum markers). This association was attenuated when using traditional single-slice area measures. Highest correlation coefficients (R) between volumetric and single-slice area body composition measures were located at vertebra L5 for SAT (R = 0.820) and SMFF (R = 0.947), at L3 for VAT (R = 0.892), SM (R = 0.944), and at L4 for IMAT (R = 0.546) (all p < 0.0001). A similar pattern was found in 23,725 NAKO participants (mean age 53.9 ± 8.3 years, age range 40-75; 44.9% female).
Interpretation: Automated volumetric body composition assessment from whole-body MRI predicted mortality in a large Western population beyond traditional clinical risk factors. Single slice areas were highly correlated with volumetric body composition measures but their association with mortality attenuated after multivariable adjustment. As volumetric body composition measures are increasingly accessible using automated techniques, identifying high-risk individuals may help to improve personalised prevention and lifestyle interventions.
Funding: This project was conducted using data from the German National Cohort (NAKO) (www.nako.de). The NAKO is funded by the Federal Ministry of Education and Research (BMBF) [project funding reference numbers: 01ER1301A/B/C, 01ER1511D, and 01ER1801A/B/C/D], federal states of Germany and the Helmholtz Association, the participating universities and the institutes of the Leibniz Association. This research has been conducted using the UK Biobank Resource under Application Number 80337. MJ was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-518480401. VKR was funded by American Heart Association Career Development Award 935176 and National Heart, Lung, and Blood Institute-K01HL168231.
Competing Interests: Declaration of interests Vineet K. Raghu: Grants or contracts from any entity: Norn Group, Johnson and Johnson Innovation, National Academy of Medicine. Tobias Pischon: Leadership in board: Member of the board of directors of the NAKO e.V., who are leading the NAKO study (unpaid position). Hans-Ulrich Kauczor: Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Siemens Healthineers, Philips, Boehringer Ingelheim Participation on a Data Safety Monitoring Board or Advisory Board: Median, contextflow. Christopher L. Schlett: Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Siemens Healthineers, Bayer Healthcare. Michael T. Lu: Grants or contracts from any entity: American Heart Association, AstraZeneca, Ionis, Johnson & Johnson Innovation, Kowa Pharmaceuticals America, MedImmune, National Academy of Medicine, National Heart, Lung, and Blood Institute, and Risk Management Foundation of the Harvard Medical Institutions. Fabian Bamberg: Grants or contracts from any entity: Siemens Healthineers, Bayer Healthcare Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events: Siemens Healthineers, Bayer Healthcare. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: German Roentgen Society. Jakob Weiss: Consulting fees: Onc.AI.
(Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)